investing

Anika Therapeutics, Inc. recently held an earnings call to discuss their second quarter 2025 financial results and provide updates on key programs. Here’s a breakdown of the information shared during the call: Hyalofast Clinical Trial Update A significant portion of the discussion focused on the Phase III clinical trial for Hyalofast, a treatment for articular […]